Short answer
Prestige Consumer Healthcare Inc. (PBH) filed its Q3 2026 10-Q quarterly report on Nov 5, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $336M (up 22.7% year over year) with net income of $25M.
Q3 2026 key financials · XBRL
- Revenue
- $336M
- +22.7% YoY · +26.6% QoQ
- Net income
- $25M
- −40.1% YoY · −13.3% QoQ
- Operating margin
- 24.0%
- Gross margin
- 51.3%
- EPS (diluted)
- $0.53
- −38.4% YoY · −13.1% QoQ
Source: XBRL data from the Prestige Consumer Healthcare Inc. (PBH) Q3 2026 10-Q on SEC EDGAR. USD.
Prestige Consumer Healthcare Inc. Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Quarterly revenue $336.3M, up 22.7% YoY from $274.1M, driven by OTC Wellness acquisition
- Gross margin 51.3% vs 55.3% YoY, pressured by Pillar5 costs and acquisition inventory step-ups
- Best category Wellness, Sleep & Other, $37.2M North America revenue, up 507.2% YoY
- International OTC strongest segment, revenue $64.5M, up 48.7% YoY
- Cash $46.5M, down $17.4M; operating cash flow $108.7M, down $27.8M YoY; acquisitions used $1.2B in investing cash
Risk Factors
- No material changes to 10-K risk factors during the quarter
- Quarterly results and revenues may fluctuate, limiting comparability across periods
- Future results below analyst or investor expectations could depress securities prices
- Unknown or currently immaterial risks could materially harm business, financial condition, or results
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Prestige Consumer Healthcare Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.